Merck Acquires Biochrom

Biochrom AG (MKGAY.PK) announced that Merck & Co. Inc.(MRK) entered into a definitive agreement to acquire Biochrom AG. The acquisition is subject to customary closing conditions, including approval by the relevant antitrust authorities.

The transaction is expected to close in the fourth-quarter of 2012.

The Berlin location Biochrom AG is to be maintained. The activities of Biochrom be integrated into the Process Solutions business unit of Merck Millipore.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Shares of Apple Inc. (AAPL) jumped nearly 5% in extended trading session on Thursday after the California-based tech giant reported first-quarter results, with both earnings and revenues trumping Wall Street's expectations, driven by strong demand for its latest iPhone 13 and other services. Apple... The U.S. Food and Drug Administration has revised the authorizations for two monoclonal antibody treatments - bamlanivimab and etesevimab (administered together) and REGEN-COV (casirivimab and imdevimab) - to limit their use to only when the patient is likely to have been infected with or exposed to a variant that is susceptible to these treatments. Comcast Corp. (CMCSA, CMCSK) on Thursday reported that net income attributable to Comcast for the quarter decreased 9.6 percent to $3.06 billion or $0.66 per share from $3.38 billion or $0.73 per share in the year-ago quarter. Excluding items, adjusted earnings for the quarter were $0.77, compared to...
Follow RTT